DV
Dividend Vision

TMDX — TransMedics Group, Inc.

TransMedics Group, Inc. (TMDX)

Total return is 296.2% over the past 7.3 years, 99.5 points ahead of SPY at 196.7%. Its deepest 1-year drawdown was 58.8%.

TransMedics Group, Inc. is a single-stock equity holding that trades as a publicly listed company rather than functioning as a diversified ETF. The stock does not currently pay dividends, so it offers no yield or regular distributions to shareholders. This holding is oriented toward investors seeking capital appreciation rather than income generation.

TMDX key facts

Asset type
Stock
Asset class
Equity
Inception date
05/02/2019
Distribution frequency
None
Last close
$88.58
Market cap
$3,071,524,352
Average volume
433900.0
Beta
1.88
Payout ratio
0.0
P/E ratio
22.9482
Forward P/E
60.6061
EPS
$3.86